These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 8546140
21. Underestimation of rat serum vancomycin concentrations measured by an enzyme-multiplied immunoassay technique and the strategy for its avoidance. Konishi H, Iga I, Nagai K. Drug Test Anal; 2014 Apr; 6(4):350-6. PubMed ID: 23943307 [Abstract] [Full Text] [Related]
26. A comparison of EMIT and FPIA methods for the detection of cyclosporin A blood levels: does impaired liver function make a difference? Witzke O, Heemann U, Thesing A, Wolfhard U, Erhard J, Philipp T, Michel MC. Eur J Clin Pharmacol; 1997 Apr; 52(5):413-6. PubMed ID: 9272414 [Abstract] [Full Text] [Related]
27. More information on vancomycin clearance by new hemodialysis membranes. Mueller BA, Scott MK, Clark WR. Am J Health Syst Pharm; 1996 Jun 01; 53(11):1339-40, 1348. PubMed ID: 8725212 [No Abstract] [Full Text] [Related]
28. Implications of vancomycin degradation products on therapeutic drug monitoring in patients with end-stage renal disease. Somerville AL, Wright DH, Rotschafer JC. Pharmacotherapy; 1999 Jun 01; 19(6):702-7. PubMed ID: 10391415 [Abstract] [Full Text] [Related]
29. Determination of N-desmethylmethsuximide serum concentrations using enzyme-multiplied and fluorescence polarization immunoassays. Miles MV, Howlett CM, Tennison MB, Greenwood RS, Cross RE. Ther Drug Monit; 1989 Jun 01; 11(3):337-42. PubMed ID: 2658212 [Abstract] [Full Text] [Related]
30. Potential problem with fluorescence polarization immunoassay cross-reactivity to vancomycin degradation product CDP-1: its detection in sera of renally impaired patients. Anne L, Hu M, Chan K, Colin L, Gottwald K. Ther Drug Monit; 1989 Sep 01; 11(5):585-91. PubMed ID: 2683253 [Abstract] [Full Text] [Related]
31. Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy. Barth RH, DeVincenzo N. Kidney Int; 1996 Sep 01; 50(3):929-36. PubMed ID: 8872968 [Abstract] [Full Text] [Related]
32. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation. Rodríguez E, Delucchi MA, Cano F, Valdebenito S, Castillo MC, Villegas R. Transplant Proc; 2005 Oct 01; 37(8):3354-7. PubMed ID: 16298594 [Abstract] [Full Text] [Related]
35. Comparison of bioassay, high-performance liquid chromatography, and fluorescence polarization immunoassay for quantitative determination of vancomycin in serum. Ristuccia PA, Ristuccia AM, Bidanset JH, Cunha BA. Ther Drug Monit; 1984 Oct 01; 6(2):238-42. PubMed ID: 6377600 [Abstract] [Full Text] [Related]
36. CAHP-210 dialyzer influence on intra-dialytic vancomycin removal. Lucksiri A, Scott MK, Mueller BA, Hamburger RJ, Sowinski KM. Nephrol Dial Transplant; 2002 Sep 01; 17(9):1649-54. PubMed ID: 12198218 [Abstract] [Full Text] [Related]